P. Mackenzie

Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.

T. Comans, M. Agar, M. Barton, 2022, Journal of geriatric oncology.

T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.

B. Panizza, M. Foote, B. Burmeister, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy for breast cancer, the TARGIT-A trial

A. Fyles, C. Chung, P. Mackenzie, 2014, The Lancet.

Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.

T. Comans, M. Agar, M. Barton, 2022, Journal of geriatric oncology.

Breast interest group faculty of radiation oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy

M. Morgia, Y. Zissiadis, P. Mackenzie, 2017, Journal of medical imaging and radiation oncology.

Gender diversity and leadership in Radiation Oncology in Australia and New Zealand

S. Turner, M. James, P. Mackenzie, 2023, Journal of medical imaging and radiation oncology.

Advanced radiotherapy techniques for breast cancer to minimize cardiovascular risk

A. Fyles, C. Chung, Wei Wang, 2014 .

Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia

T. Comans, M. Agar, M. Barton, 2020, Technical innovations & patient support in radiation oncology.

Development of an Age- and Comorbidity- Adjusted Optimal Radiotherapy Utilisation Rate for Lung, Rectal, Prostate and Cervical Cancers.

T. Comans, M. Agar, M. Barton, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.